Pharmaceutical compositions comprising natriuretic peptides...

Details Pharmaceutical compositions comprising natriuretic peptides... Pharmaceutical compositions comprising natriuretic peptides...

A - Human Necessities

61

K

A61K 38/22 (2006.01) A61K 38/04 (2006.01) A61K 38/55 (2006.01)

Patent

CA 2119019

2119019 9305809 PCTABS00021 Treatment or prevention of myointimal proliferation in atherosclerosis, restenosis induced by angioplasty or vascular reconstructive surgery, glomerulonephritis, glomerulosclerosis or other diseases involving vascular cell proliferation, with a natriuretic peptide or a neutral endopeptidase inhibitor such as N-[N-[(L)-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl]-2-phenylethyl_ ]-L-phenylalanyl]-.beta.-alanine and N-[2-mercaptomethyl-3-(2-methylphenyl)propionyl]-methionine, or with a neutral endopeptidase inhibitor in combination with a natriuretic peptide or an angiotensin converting enzyme inhibitor are disclosed.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions comprising natriuretic peptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions comprising natriuretic peptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising natriuretic peptides... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1417309